BioSpace News Archive

New FDA-approved vaccine offers more effective protection and can be used in younger patients

Strategic Advisor Brings Extensive Experience in AI, Blockchain and Healthcare to Innovative Health-Tech Company

Siemens AG and Process Systems Enterprise (PSE), the Advanced Process Modelling (APM) company, today announced at Achema that they have signed a long-term collaboration agreement to bring the power of PSE’s gPROMS APM technology to Siemens automation and digitalization offerings for the process industries.

IsoPlexis Corporation (IsoPlexis) today announced the publication of clinical data demonstrating a significant association between the functionality of anti-CD19 CAR-T cell product before treatment, as defined by IsoPlexis’ Polyfunctional Strength Index (PSI), and the objective response in patients with non-Hodgkin lymphoma.

Kewaunee Scientific Corporation announced that the Company plans to release its fourth quarter and fiscal year end 2018 financial results on Tuesday, June 26, 2018 after the close of trading.

Tyber Medical announces the promotion of Gary Thomas to Chief Operating Officer and the addition of Wesley Johnson as Executive Vice President of Product Development.

Merck announced that the U.S. Food and Drug Administration (FDA) has approved KEYTRUDA®

Cellectis announced the publication of a study in Scientific Reports, a Nature Publishing Group journal.

vTv Therapeutics Inc. today announced that results from Part B of the Company’s STEADFAST Study of the investigational medication azeliragon in people with mild Alzheimer’s disease did not meet co-primary efficacy endpoints.

IQVIA Holdings Inc. announced the launch of an underwritten, secondary public offering of 12,000,000 shares of its common stock by certain of its existing stockholders